Therapeutic efficacy of rscAAVrh74.miniCMV.LIPA gene therapy in a mouse model of lysosomal acid lipase deficiency
Lysosomal acid lipase deficiency (LAL-D) presents as one of two rare autosomal recessive diseases: Wolman disease (WD), a severe disorder presenting in infancy characterized by absent or very low LAL activity, and cholesteryl ester storage disease (CESD), a less severe, later onset disease form. Rec...
Main Authors: | Patricia Lam, Anna Ashbrook, Deborah A. Zygmunt, Cong Yan, Hong Du, Paul T. Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050122001115 |
Similar Items
-
Progressive macrophage accumulation in lysosomal acid lipase deficiency
by: Patryk Lipiński, et al.
Published: (2020-06-01) -
Mexican consensus on lysosomal acid lipase deficiency diagnosis
by: R. Vázquez-Frias, et al.
Published: (2018-01-01) -
Mutations identified in a cohort of Mexican patients with lysosomal acid lipase deficiency
by: Alejandra Consuelo-Sánchez, et al.
Published: (2019-07-01) -
Frequency of lysosomal acid lipase deficiency in patients with primary hyperlipidemia
by: Bahri Evren, et al.
Published: (2019-06-01) -
Lysosomal Acid Lipase Deficiency: Genetics, Screening, and Preclinical Study
by: Ryuichi Mashima, et al.
Published: (2022-12-01)